Hodgkin Lymphoma: Clinical Trials

4 trials for Hodgkin Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1

Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Brentuximab Vedotin, Doxorubicin, Vinblastine - Hodgkin Lymphoma
Phase 4RecruitingTakeda1242024-08-282026-02-23
Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma
Pentoxifylline, Placebo - Hodgkin Lymphoma
Phase 4UnknownUniversity of Guadalajara302022-07-112023-04-18
CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma
Combined chemotherapy with or without involved-field radiotherapy - Hodgkin Lymphoma
Phase 4Active not recruitingChildren's Cancer Group, China2002018-04-012026-03-19
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Brentuximab Vedotin - Hodgkin Lymphoma
Phase 4CompletedMillennium Pharmaceuticals, Inc.602014-03-142021-04-09

Narrower conditions

Hodgkin Disease (4)  ·  Lymphoma (2)  ·  Hematologic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, T-Cell (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Recurrence (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Lymphoma (2)  ·  Disease Attributes (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Brentuximab Vedotin (2)  ·  Dacarbazine (1)  ·  Doxorubicin (1)  ·  Pentoxifylline (1)  ·  Vinblastine (1)

Sponsors

Children's Cancer Group, China (1)  ·  Millennium Pharmaceuticals, Inc. (1)  ·  Takeda (1)  ·  University of Guadalajara (1)

Countries

China (1)  ·  Czechia (1)  ·  Germany (1)  ·  India (1)  ·  Malaysia (1)  ·  Mexico (1)  ·  Poland (1)  ·  Spain (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 23275102, PMID 25311218, PMID 31539308